Isofol to present at upcoming investor meetings in December
GOTHENBURG, Sweden, November 20, 2026 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) announces today that the company will participate […]
GOTHENBURG, Sweden, November 20, 2026 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) announces today that the company will participate […]
GOTHENBURG, Sweden, 13 November 2026 – Isofol Medical AB (“Isofol” or the “Company”) carried out a rights issue of units
GOTHENBURG, Sweden, November 12, 2026 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), (”Isofol” or the ”Company”), announced today that
GOTHENBURG, Sweden, November 10, 2026 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) today provides an update on the company’s
GOTHENBURG, Sweden, October 28, 2026 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), (”Isofol” or the ”Company”), announced today that
GOTHENBURG, Sweden, October 13, 2026 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) invites investors, shareholders and other stakeholders to
GOTHENBURG, Sweden, September 22, 2026 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) announces today that the company will be
GOTHENBURG, Sweden, August 25, 2026 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), (”Isofol” or the ”Company”), announced today that
GOTHENBURG, Sweden, August 24, 2026 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces that the company includes additional clinical
GOTHENBURG, Sweden, July 8, 2026 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the company has completed